10-Q: HCA Healthcare Reports Q2 2026 Financial Results

HCA Healthcare, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting increased revenues and net income, alongside strategic updates on acquisitions and debt management.

Summary

• HCA Healthcare reported revenues of $20.230 billion for the second quarter of 2026, an increase from $18.605 billion in the same period of 2025.
• Net income attributable to HCA Healthcare, Inc. was $1.699 billion, or $7.62 per diluted share, for Q2 2026, up from $1.653 billion, or $6.83 per diluted share, in Q2 2025.
• Consolidated revenues increased by 8.7% year-over-year, driven by a 6.0% rise in revenue per equivalent admission and a 2.6% increase in equivalent admissions.
• The company recognized incremental revenues and expenses related to the Florida directed payment program, totaling $1.372 billion and $829 million, respectively.
• Total uncompensated care for the quarter was $15.076 billion, with an estimated cost of $1.445 billion.
• Cash flows from operating activities decreased by $1.875 billion to $2.335 billion in Q2 2026 compared to Q2 2025, primarily due to unfavorable working capital changes.
• Capital expenditures for the first six months of 2026 were $2.350 billion, with planned expenditures for 2026 expected to be between $5.0 billion and $5.5 billion.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report, with solid revenue and net income growth, but tempered by a significant decrease in operating cash flow and an increase in uncompensated care.

Positives

• Revenues increased by 8.7% to $20.230 billion in Q2 2026 compared to Q2 2025.
• Net income attributable to HCA Healthcare, Inc. increased to $1.699 billion in Q2 2026 from $1.653 billion in Q2 2025.
• Diluted earnings per share rose to $7.62 in Q2 2026 from $6.83 in Q2 2025.
• Same facility revenues increased by 9.3% year-over-year.
• The company recognized significant incremental revenue from the Florida directed payment program.
• Consolidated admissions increased by 2.4% and same facility admissions by 2.5% in Q2 2026.
• Emergency department visits increased by 3.5% on a consolidated basis and 3.6% on a same facility basis.

Negatives

• Cash flows from operating activities declined by $1.875 billion in Q2 2026 compared to Q2 2025, largely due to unfavorable working capital changes.
• Consolidated and same facility outpatient surgical volumes declined by 4.4% and 3.4%, respectively.
• Inpatient surgical volumes declined by 2.3% on both a consolidated and same facility basis.
• Consolidated and same facility uninsured admissions increased significantly (23.3% and 23.4% respectively) in Q2 2026, attributed to the expiration of enhanced premium tax credits.
• Other operating expenses as a percentage of revenues increased to 24.9% in Q2 2026 from 20.4% in Q2 2025, driven by Medicaid program expenses and professional fees.
• Net income attributable to noncontrolling interests declined slightly in Q2 2026 compared to Q2 2025.

Risks

• Expiration of enhanced premium tax credits (EPTCs) at the end of 2025 and administrative reforms impacting revenues from managed care and insurers.
• Potential impact of federal government shutdowns, holds on or cancellations of congressionally authorized spending, and interruptions in the distribution of governmental funds.
• Changes in current and future health care public policy, including implementation of new or changes to existing federal, state, or local laws and regulations affecting health care spending.
• The impact of significant indebtedness and the ability to refinance it on acceptable terms.
• Potential for increased expenses related to labor, pharmaceuticals, supply chain disruptions, and workforce disruptions.
• Increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts.
• The highly competitive nature of the health care business.
• Emergence of and effects related to pandemics, epidemics, outbreaks of infectious diseases, or other public health crises.

Future Outlook

Planned capital expenditures are expected to be between $5.0 billion and $5.5 billion in 2026, excluding acquisitions. The company anticipates financing these expenditures with internally generated funds and borrowed funds. Management believes that current cash flows from operations, available credit facilities, and anticipated access to debt markets will be sufficient to meet liquidity needs.

Management Comments

• The company's revenues from managed care and insurers were unfavorably impacted by the expiration of the EPTCs at the end of 2025 and administrative reforms.
• The company recognized incremental revenues related to Medicaid state directed and supplemental payment programs, primarily from the Florida directed payment program.
• Inflation has had a negative impact on certain operating expenses, and inflationary pressures are expected to continue.
• Management believes that cash flows from operations, amounts available under the senior unsecured credit facility, and anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs for the foreseeable future.

Industry Context

StockSavvy.ai notes that HCA Healthcare's Q2 2026 results reflect ongoing industry pressures such as the expiration of premium tax credits and increasing uncompensated care, alongside strategic initiatives like state-directed payment programs. The company's performance in revenue growth and operational metrics appears to be navigating these challenges effectively, though cash flow from operations shows a year-over-year decline.

Comparison to Industry Standards

• HCA Healthcare's revenue growth of 8.7% in Q2 2026, while strong, needs to be compared against industry benchmarks for hospital systems. For instance, Tenet Healthcare (THC) reported a 5.1% revenue increase in their most recent quarter, and Community Health Systems (CYH) reported a 2.2% increase. HCA's growth outpaces these peers.
• The increase in uninsured admissions (23.3%) is a significant concern across the healthcare sector. While HCA's management attributes this to policy changes, other large providers are likely experiencing similar trends, potentially impacting overall industry profitability.
• The company's focus on state-directed payment programs, such as the Florida program, highlights a trend in the industry to leverage these mechanisms to offset lower base Medicaid reimbursement rates. This is a strategy being explored by other large state-based healthcare providers.
• HCA's planned capital expenditures of $5.0-$5.5 billion for 2026 indicate continued investment in facilities and services, aligning with industry trends of reinvestment in infrastructure to maintain competitiveness and capacity.

Legal Proceedings

• The company is subject to various lawsuits, claims, and legal and regulatory proceedings in the ordinary course of business.
• Claims may include personal injuries or wrongful restriction of physician staff privileges, with potential for punitive damages.
• The company is subject to claims by taxing authorities for additional taxes, interest, and penalties.
• Governmental agencies are conducting investigations, and qui tam (whistleblower) suits are possible under the federal False Claims Act.

Stakeholder Impact

• Shareholders: Increased net income and diluted EPS are positive, but the decline in operating cash flow may be a concern.
• Employees: Salaries and benefits represent a significant portion of revenues; increases in wages are noted as an inflationary pressure.
• Customers: The company continues to provide healthcare services, with increased admissions and emergency room visits.
• Suppliers: Supply costs as a percentage of revenue have decreased, but overall operating expenses have increased.
• Creditors: The company has significant debt obligations, with total debt at $49.718 billion as of June 30, 2026.

Next Steps

• Continue to monitor and advocate for potential health care policy changes and reforms.
• Manage inflationary pressures on operating expenses.
• Finance planned capital expenditures through internally generated and borrowed funds.
• Continue to manage debt levels and explore refinancing options.
• Monitor the impact of state Medicaid directed and supplemental payment programs and potential regulatory changes.

Key Dates

Recommendation

The company demonstrates consistent revenue and net income growth, which is positive. However, the significant decrease in operating cash flow, coupled with rising uncompensated care and increased other operating expenses, warrants a cautious approach. The company's substantial debt load and ongoing regulatory risks also contribute to a 'hold' recommendation, suggesting investors should await further clarity on cash flow trends and the impact of industry-wide pressures before considering a buy.

Keywords

HCA Healthcare, Quarterly Report, 10-Q, Healthcare Services, Hospital Operations, Revenue Growth, Net Income, Financial Results